Business Description
![Botanix Pharmaceuticals Ltd Botanix Pharmaceuticals Ltd logo](https://static.gurufocus.com/logos/0C00000LD0.png?14)
Botanix Pharmaceuticals Ltd
NAICS : 325414
SIC : 2836
ISIN : AU000000BOT2
Description
Botanix Pharmaceuticals Ltd is a clinical-stage cannabinoid therapeutics company. The company's focus is the development of safe and effective topical treatments for serious skin conditions. It has an exclusive license to use a proprietary drug delivery system - Permetrex for direct skin delivery of active pharmaceuticals in all skin diseases. The company's product pipeline includes BTX1503 - Moderate to Severe Acne, BTX1308 - Plaque Psoriasis, BTX1204 - Atopic Dermatitis, and BTX 1701 - Mild Acne. The majority of Revenue is Derived from Australia.
Financial Strength
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.95 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 177.26 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 23.7 | |||||
3-Year EPS without NRI Growth Rate | 23.7 | |||||
3-Year FCF Growth Rate | 3.6 | |||||
3-Year Book Growth Rate | -10.9 | |||||
Future 3-5Y Total Revenue Growth Rate | 1066.39 |
Momentum Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 51.1 | |||||
9-Day RSI | 54.24 | |||||
14-Day RSI | 55.81 | |||||
6-1 Month Momentum % | 97.14 | |||||
12-1 Month Momentum % | 155.56 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 9.5 | |||||
Quick Ratio | 8.14 | |||||
Cash Ratio | 7.99 | |||||
Days Sales Outstanding | 1049.87 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -10.5 | |||||
Shareholder Yield % | -6.34 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 469.89 | |||||
Operating Margin % | -10795.7 | |||||
Net Margin % | -10778.5 | |||||
FCF Margin % | -28839.78 | |||||
ROE % | -35.33 | |||||
ROA % | -32.23 | |||||
ROIC % | -62 | |||||
ROC (Joel Greenblatt) % | -1092.33 | |||||
ROCE % | -35.29 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 12.77 | |||||
Price-to-Tangible-Book | 37 | |||||
EV-to-EBIT | -66.03 | |||||
EV-to-EBITDA | -66.72 | |||||
EV-to-Revenue | 7107.87 | |||||
EV-to-FCF | -21.02 | |||||
Price-to-Net-Current-Asset-Value | 37 | |||||
Price-to-Net-Cash | 37 | |||||
Earnings Yield (Greenblatt) % | -1.51 | |||||
FCF Yield % | -4 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Botanix Pharmaceuticals Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil A$) | 0.093 | ||
EPS (TTM) (A$) | -0.007 | ||
Beta | 2.38 | ||
Volatility % | 74.09 | ||
14-Day RSI | 55.81 | ||
14-Day ATR (A$) | 0.023195 | ||
20-Day SMA (A$) | 0.3555 | ||
12-1 Month Momentum % | 155.56 | ||
52-Week Range (A$) | 0.115 - 0.405 | ||
Shares Outstanding (Mil) | 1,810.04 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Botanix Pharmaceuticals Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Botanix Pharmaceuticals Ltd Stock Events
Event | Date | Price(A$) | ||
---|---|---|---|---|
No Event Data |
Botanix Pharmaceuticals Ltd Frequently Asked Questions
What is Botanix Pharmaceuticals Ltd(ASX:BOT)'s stock price today?
The current price of ASX:BOT is A$0.37. The 52 week high of ASX:BOT is A$0.41 and 52 week low is A$0.12.
When is next earnings date of Botanix Pharmaceuticals Ltd(ASX:BOT)?
The next earnings date of Botanix Pharmaceuticals Ltd(ASX:BOT) is .
Does Botanix Pharmaceuticals Ltd(ASX:BOT) pay dividends? If so, how much?
Botanix Pharmaceuticals Ltd(ASX:BOT) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |